In a year that began with so much promise on the COVID-19 front, we now face deadly familiar headlines and new threats such as the Omicron variant that has the world on alert. This latest blow comes amid alarming and widespread spikes in infections globally, a still pernicious Delta variant, and rapidly climbing numbers of […]

Cyclacel (Berkeley Heights, NJ) is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology. Its aim is to build a diversified biopharma business based on a pipeline of novel drug candidates that address oncology and hematology indications. President and CEO Spiro Rombotis joined the company as its […]

New pharmacotherapies and novel approaches, such as gene therapy and cell therapy, are raising realistic hopes for patients with geographic atrophy, a condition that can lead to vision loss. “There has been a tremendous amount of clinical research looking at different therapeutic avenues for geographic atrophy, and we have had some prominent disappointments over the […]